Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2348 (LINC02348) is a noncoding RNA gene (Ensembl ID: ENSG00000273585) that generates long intergenic non-coding RNA transcripts. These RNAs are not translated into proteins but can function as regulatory molecules, affecting transcription, splicing, and chromatin architecture by interacting with transcription factors, splicing factors, and epigenetic proteins. LINC02348 is differentially expressed in certain cancer types such as kidney clear cell carcinoma (KIRC), and may regulate disease processes through epigenetic and transcriptional modulation, though specific roles and disease mechanisms remain understudied relative to other lincRNAs. It is not an established receptor, enzyme, or classical drug target, but is a molecular element relevant to functional genomics and disease association studies in cancer biology.
None established, due to lack of direct drug interactions or target-focused therapeutics
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2348 (LINC02348).